Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 9/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 9/20 | 0.46 |
| ▸ | MAPT | P10636 | 8/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.46 |
| ▸ | HPGD | P15428 | 7/20 | 0.46 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.43 |
| ▸ | PLA2G2A | P14555 | 3/20 | 0.42 |
| ▸ | PLA2G4A | P47712 | 3/20 | 0.42 |
| ▸ | AHR | P35869 | 2/20 | 0.41 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.41 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | CASP3 | P42574 | 1/20 | 0.40 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24216370 | 0.97 | KMT2A (0.45) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL17899243 | 0.96 | MEN1 (0.43) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL26004271 | 0.96 | KMT2A (0.45) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL24217076 | 0.96 | MEN1 (0.47) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL19278218 | 0.95 | MEN1 (0.44) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL19276008 | 0.95 | MEN1 (0.44) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL17899223 | 0.95 | HCRTR1 (0.41) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL22329894 | 0.94 | MEN1 (0.53) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL22329946 | 0.94 | MEN1 (0.49) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL18698037 | 0.94 | MEN1 (0.51) | MEN1KMT2AMAPTALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230301183-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-09-21 | — | — | US | disclosed |
| US-20230301183-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-09-21 | — | — | US | disclosed |
| US-20230263054-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-08-17 | — | — | US | disclosed |
| US-20230263054-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-08-17 | — | — | US | disclosed |
| US-20230172065-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-06-01 | — | — | US | disclosed |
| US-20230172065-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-06-01 | — | — | US | disclosed |
| WO-2022025714-A1 | ORGANIC LIGHT EMITTING DEVICE | 주식회사 엘지화학 | 2022-02-03 | — | — | WO | disclosed |
| WO-2022015084-A1 | ORGANIC LIGHT-EMITTING ELEMENT | 주식회사 엘지화학 | 2022-01-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230172065-A1 | ORGANIC LIGHT EMITTING DEVICE | CRY1, CYP1A2, CYP1A1 | MEN1 1920/4885KMT2A 1792/4885MAPT 766/4885 |
| US-20230301183-A1 | ORGANIC LIGHT EMITTING DEVICE | CRY1, CRY2, CYP1A1 | MEN1 929/4885KMT2A 2084/4885MAPT 1437/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.